SCHEMBL10019992

SCHEMBL10019992

CCCc1ccc(-c2ccc3c(c2F)C(F)(F)C(F)(F)c2c-3ccc(OCC)c2F)cc1F

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 5/20 0.38
GABRB2 P47870 5/20 0.38
FGFR2 P21802 2/20 0.38
FGFR1 P11362 1/20 0.38
NAAA Q02083 1/20 0.34
CTSL P07711 1/20 0.33
CTSS P25774 1/20 0.33
CTSK P43235 1/20 0.33
RET P07949 4/20 0.33
KDR P35968 3/20 0.33
ALOX5 P09917 1/20 0.32
PTPRC P08575 1/20 0.32
ATM Q13315 1/20 0.31
FPR2 P25090 1/20 0.31
NLRP3 Q96P20 1/20 0.30
GABRA5 P31644 1/20 0.30
GABRA3 P34903 1/20 0.30
GABRA2 P47869 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10019977 0.88 GABRA1 (0.35) GABRA1GABRB2FGFR2FGFR1NAAA
SCHEMBL22809285 0.88 GABRA1 (0.44) GABRA1GABRB2FGFR2FGFR1NAAA
SCHEMBL10019998 0.86 L3MBTL1 (0.38) FGFR2FGFR1
SCHEMBL10019549 0.85 CTSL (0.40) GABRA1GABRB2FGFR2FGFR1CTSL
SCHEMBL10020137 0.85 RXRG (0.39) GABRA1GABRB2CTSLCTSSCTSK
SCHEMBL10019620 0.84 CACNA1C (0.36) GABRA1GABRB2CTSLCTSSCTSK
SCHEMBL10020025 0.84 GABRA1 (0.37) GABRA1GABRB2CTSLCTSSCTSK
SCHEMBL10019997 0.84 CTSS (0.46) GABRA1GABRB2FGFR2FGFR1CTSL
SCHEMBL10019986 0.83 FFAR4 (0.36) GABRA1GABRB2FGFR2FGFR1ALOX5
SCHEMBL10020019 0.83 GABRA1 (0.38) GABRA1GABRB2CTSLCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2669263-B1 COMPOUND CONTAINING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORP (JP) 2017-11-22 EP disclosed
US-9193908-B2 Compound having dihydrophenanthrene, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2015-11-24 US disclosed
US-9193908-B2 Compound having dihydrophenanthrene, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2015-11-24 US disclosed
US-20130240784-A1 COMPOUND HAVING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC PETROCHEMICAL CORPORATION (JP) 2013-09-19 US disclosed
US-20130240784-A1 COMPOUND HAVING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC PETROCHEMICAL CORPORATION (JP) 2013-09-19 US disclosed
WO-2012086437-A1 COMPOUND CONTAINING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY JNC株式会社 (JP) 2012-06-28 WO disclosed